Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 1,000,000 TCRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 1,000,000 | n/a |
| Jan 22, 2026 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 1,165,000 | n/a |
| Feb 11, 2025 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 160,000 | n/a |
| Jun 15, 2023 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 1,121,300 | n/a |
| Feb 6, 2023 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 40,000 | n/a |
| Jul 27, 2022 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 100,000 | n/a |
| Jan 20, 2022 | TScan Therapeutics, Inc. (TCRX) | Grant/Award | 140,000 | n/a |
| Sep 22, 2021 | TScan Therapeutics, Inc. (TCRX) | Purchase | 4,943 | $30.7K |